Medical therapy of stone disease: From prevention to promotion of passage options

Current Urology Reports

Volumn 10, Issue 1, 2009, Pages 29-34

  Lipkin, Michael ^b   Shah, Ojas ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALLOPURINOL; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIUROLITHIASIS AGENT; CALCIUM CHANNEL BLOCKING AGENT; CITRATE POTASSIUM; CITRATE POTASSIUM SODIUM; CITRATE SODIUM; COTRIMOXAZOLE; DEFLAZACORT; DICLOFENAC; DOXAZOSIN; INDAPAMIDE; METHYLPREDNISOLONE; NIFEDIPINE; PHLOROGLUCINOL; POTASSIUM MAGNESIUM CITRATE; PREDNISONE; TAMSULOSIN; TERAZOSIN; THIAZIDE DIURETIC AGENT; TOLTERODINE; TRICHLORMETHIAZIDE; UNCLASSIFIED DRUG;

CALCIUM OXALATE STONE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DRUG RECEPTOR BINDING; FLUID INTAKE; GASTROINTESTINAL SYMPTOM; HUMAN; IDIOPATHIC HYPERCALCIURIA; KIDNEY COLIC; LEMON; LIME (FRUIT); PAIN; REVIEW; SODIUM RESTRICTION; URETER STONE; UROLITHIASIS;

CALCIUM CHANNEL BLOCKERS; HUMANS; HYDROGEN-ION CONCENTRATION; URINARY CALCULI;

EID: 58149458889     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-009-0007-x     Document Type: Review

References (49)

1. Pietrow PK, Preminger GM: Evaluation and medical management of urinary lithiasis. In Campbell-Walsh Urology. Edited by Wein AJ, Kavoussi LR, Novick AC, et al.: Philadelphia: Saunders Elsevier; 2007:1393-1430.
2. M.S. Pearle C.G. Roehrborn C.Y. Pak 1999 Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis J Endourol 13 679 685
3. B. Ettinger A. Tang J.T. Citron 1986 Randomized trial of allopurinol in the prevention of calcium oxalate calculi N Engl J Med 315 1386 1389
4. H.K. Mardis J.H. Parks G. Muller 2004 Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice J Urol 171 85 88
5. Y. Lotan M.S. Pearle 2007 Economics of stone management Urol Clin North Am 34 443 453
6. G.M. Preminger H.G. Tiselius D.G. Assimos 2007 2007 guideline for the management of ureteral calculi J Urol 178 2418 2434
7. O.F. Miller C.J. Kane 1999 Time to stone passage for observed ureteral calculi: a guide for patient education J Urol 162 688 690
8. J.M. Hollingsworth M.A. Rogers S.R. Kaufman 2006 Medical therapy to facilitate urinary stone passage: a metaanalysis Lancet 368 1171 1179
9. K. Bensalah M. Pearle Y. Lotan 2008 Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones Eur Urol 53 411 418
10. S. Park M.S. Pearle 2007 Pathophysiology and management of calcium stones Urol Clin North Am 34 323 334
11. P. Barcelo O. Wuhl E. Servitge 1993 Randomized doubleblind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis J Urol 150 1761 1764
12. B. Ettinger C.Y. Pak J.T. Citron 1997 Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis J Urol 158 2069 2073
13. J. Hofbauer K. Hobarth N. Szabo M. Marberger 1994 Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis-a prospective randomized study Br J Urol 73 362 365
14. K.L. Penniston S.Y. Nakada R.P. Holmes D.G. Assimos 2008 Quantitative assessment of citric acid in lemon juice, lime juice, and commercially available fruit juice products J Endourol 22 567 570
15. G.E. Haleblian V.A. Leitao S.A. Pierre 2008 Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis J Endourol 22 1359 1366
16. M.A. Seltzer R.K. Low M. McDonald 1996 Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis J Urol 156 907 909
17. D.E. Kang R.L. Sur G.E. Haleblian 2007 Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis J Urol 177 1358 1362
18. K.L. Penniston T.H. Steele S.Y. Nakada 2007 Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation Urology 70 856 860
19. S.G. Koff E.L. Paquette J. Cullen 2007 Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation Urology 69 1013 1016
20. C.V. Odvina 2006 Comparative value of orange juice versus lemonade in reducing stone-forming risk Clin J Am Soc Nephrol 1 1269 1274
21. M. Ohkawa S. Tokunaga T. Nakashima 1992 Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria Br J Urol 69 571 576
22. C.Y. Pak H.J. Heller M.S. Pearle 2003 Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions J Urol 169 465 469
23. L. Borghi T. Meschi A. Guerra A. Novarini 1993 Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences J Cardiovasc Pharmacol 22 S78 S86
24. M.J. Nicar R. Peterson C.Y. Pak 1984 Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis J Urol 131 430 433
25. C.V. Odvina G.M. Preminger J.S. Lindberg 2003 Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis Kidney Int 63 240 247
26. J.M. Malin Jr R.F. Deane S. Boyarsky 1970 Characterisation of adrenergic receptors in human ureter Br J Urol 42 171 174
27. S. Sigala M. Dellabella G. Milanese 2005 Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter Neurourol Urodyn 24 142 148
28. T. Morita I. Wada H. Saeki 1987 Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs J Urol 137 132 135
29. R.M. Weiss A.L. Bassett B.F. Hoffman 1978 Adrenergic innervation of the ureter Invest Urol 16 123 127
30. C.D. Richardson C.F. Donatucci S.O. Page 1997 Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes Prostate 33 55 59
31. I. Cervenakov J. Fillo J. Mardiak 2002 Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker-tamsulosin Int Urol Nephrol 34 25 29
32. M. Dellabella G. Milanese G. Muzzonigro 2003 Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones J Urol 170 2202 2205
33. M. De Sio R. Autorino G. Di Lorenzo 2006 Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience J Endourol 20 12 16
34. M. Dellabella G. Milanese G. Muzzonigro 2005 Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi J Urol 174 167 172
35. F. Porpiglia G. Ghignone C. Fiori 2004 Nifedipine versus tamsulosin for the management of lower ureteral stones J Urol 172 568 571
36. S. Erturhan A. Erbagci F. Yagci 2007 Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones Urology 69 633 636
37. R. Autorino M. De Sio R. Damiano 2005 The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand? Urol Res 33 460 464
38. C.J. Wang S.W. Huang C.H. Chang 2008 Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones J Endourol 22 41 46
39. E. Yilmaz E. Batislam M.M. Basar 2005 The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones J Urol 173 2010 2012
40. S. Resim H. Ekerbicer A. Ciftci 2005 Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus Int J Urol 12 615 620
41. R.N. Pedro B. Hinck K. Hendlin 2008 Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study J Urol 179 2244 2247
42. Weiss RM: Physiology and pharmacology of the renal pelvis and ureter. In Campbell-Walsh Urology. Edited by Wein AJ, Kavoussi LR, Novick AC, et al.: Philadelphia: Saunders Elsevier; 2007:1891-1921.
43. K. Davenport A.G. Timoney F.X. Keeley 2006 A comparative in vitro study to determine the beneficial effect of calciumchannel and alpha(1)-adrenoceptor antagonism on human ureteric activity BJU Int 98 651 655
44. L. Borghi T. Meschi F. Amato 1994 Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study J Urol 152 1095 1098
45. F. Porpiglia P. Destefanis C. Fiori D. Fontana 2000 Effectiveness of nifedipine and defl azacort in the management of distal ureter stones Urology 56 579 582
46. J.T. Cooper G.M. Stack T.P. Cooper 2000 Intensive medical management of ureteral calculi Urology 56 575 578
47. F. Porpiglia D. Vaccino M. Billia 2006 Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 50 339 344
48. M. Dellabella G. Milanese G. Muzzonigro 2005 Medicalexpulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life Urology 66 712 715
49. E. Laerum O.E. Ommundsen J.E. Gronseth 1995 Oral diclofenac in the prophylactic treatment of recurrent renal colic. A double-blind comparison with placebo Eur Urol 28 108 111